ACADIA PHARMACEUTICALS INC (ACAD) Institutional Ownership and Insiders Activity
ACADIA PHARMACEUTICALS INC (ACAD) is widely held by institutional investors, with 343 firms reporting positions valued at approximately $4.21B based on SEC Form 13F filings for the quarter ended June 30, 2026.
Baker Bros. Advisors Lp is the largest disclosed holder, reporting approximately $1.09B in ACAD holdings in its latest filing.
Recent insider activity includes 6 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
343
Total Reported Value
$4.21B
Largest Holder
Baker Bros. Advisors Lp
Largest Position
$1.09B
Insider Transactions (90d)
6
Latest Filing Quarter
Q2 2026
New Institutional Positions
50
Funds Exiting Positions
46
Top Institutional Owners
View allInvestorReported Balance
- Baker Bros. Advisors Lp$1.09B
- Blackrock, Inc.$569.63M
- State Street Corp$229.63M
- Vanguard Portfolio Management Llc$223.61M
- Rtw Investments, Lp$180.76M
ACAD News
All news- Baker Bros. Advisors Q2 2026 Investment Activity: Significant Shifts in Biotech Portfolio
Aug 19, 2026 · valut.ai
Related ACAD Institutional Insights:
- ACAD 13F Institutional Holders
- ACAD Superinvestors
- ACAD Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- ACAD Insider Trading & SEC Form 4 Activity
- ACAD Articles
- Top Institutional Investor Stock Rankings